skip to Main Content

News

Latest News, Announcements, and Press Releases

23Apr 18

Porton Pharma Solutions and Codexis Launch Global Partnership

View translation: Japanese | Simplified Chinese | Traditional Chinese Redwood City, Calif., and Chongqing, China (April 23, 2018) – Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology…
read more
23Apr 18

Porton Pharma Solutions and Codexis Launch Global Partnership

REDWOOD CITY, Calif. & CHONGQING, China –(BUSINESS WIRE)–Apr. 23, 2018– Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active
read more
05Apr 18

Codexis Announces Pricing of Public Offering of Common Stock

REDWOOD CITY, Calif. , April 05, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of $9.25…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins with Codexis

Back To Top
Close search
Search